Publikationen von Maria Bräutigam

Shen, D.; Silva Seco, B. M.; Teixeira Alves, L. G.; Yao, L.; Bräutigam, M.; Opitz, B.; Witzenrath, M.; Fries, B. C.; Seeberger, P. H.: Semisynthetic glycoconjugate vaccine lead against klebsiella pneumoniae serotype O2afg induces functional antibodies and reduces the burden of acute pneumonia. Journal of the American Chemical Society 146 (51), S. 35356 - 35366 (2024)

Kaplonek, P.; Yao, L.; Reppe, K.; Voß, F.; Kohler, T.; Ebner, F.; Schäfer, A.; Blohm, U.; Priegue, P.; Bräutigam, M. et al.; Pereira, C. L.; Parameswarappa, S. G.; Emmadi, M.; Ménová, P.; Witzenrath, M.; Hammerschmidt, S.; Hartmann, S.; Sander, L. E.; Seeberger, P. H.: A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae. Vaccine (2022)

Wawrzinek, R.; Wamhoff, E.-C.; Lefebre, J.; Rentzsch, M.; Bachem, G.; Domeniconi, G.; Schulze, J.; Fuchsberger, F. F.; Zhang, H.-X.; Modenutti, C. et al.; Schnirch, L.; Marti, M. A.; Schwardt, O.; Bräutigam, M.; Guberman, M.; Hauck, D.; Seeberger, P. H.; Seitz, O.; Titz, A.; Ernst, B.; Rademacher, C.: A remote secondary binding pocket promotes heteromultivalent targeting of DC-SIGN. Journal of the American Chemical Society 143 (45), S. 18977 - 18988 (2021)

Bröcker, F.; Wegner, E.; Silva Seco, B. M.; Kaplonek, P.; Bräutigam, M.; Ensser, A.; Pfister, F.; Daniel, C.; Martin, C. E.; Mattner, J. et al.; Seeberger, P. H.: Synthetic oligosaccharide-based vaccines protect mice from clostridioides difficile infections. ACS Chemical Biology 14 (12), S. 2720 - 2728 (2019)

Guberman, M.; Bräutigam, M.; Seeberger, P. H.: Automated glycan assembly of Lewis type I and II oligosaccharide antigens. Chemical Science 10 (21), S. 5634 - 5640 (2019)